AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 77 filers reported holding AKCEA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,351,000 | +23.9% | 129,589 | -6.4% | 0.04% | +40.0% |
| Q2 2020 | $1,897,000 | -22.3% | 138,478 | -18.9% | 0.02% | -34.2% |
| Q1 2020 | $2,441,000 | -23.8% | 170,720 | -9.7% | 0.04% | +52.0% |
| Q4 2019 | $3,204,000 | +12.2% | 189,124 | +2.0% | 0.02% | +13.6% |
| Q3 2019 | $2,855,000 | -37.0% | 185,498 | -4.1% | 0.02% | -35.3% |
| Q2 2019 | $4,535,000 | -14.6% | 193,375 | +27.5% | 0.03% | -2.9% |
| Q3 2018 | $5,312,000 | +81.6% | 151,688 | +23.0% | 0.04% | +84.2% |
| Q2 2018 | $2,925,000 | – | 123,368 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iguana Healthcare Management, LLC | 100,000 | $1,736,000 | 1.13% |
| BB BIOTECH AG | 1,248,650 | $21,677,000 | 0.61% |
| Virtus ETF Advisers LLC | 18,071 | $314,000 | 0.39% |
| Eventide Asset Management | 420,000 | $7,291,000 | 0.38% |
| Granahan Investment Management | 194,376 | $3,374,000 | 0.26% |
| ALTRINSIC GLOBAL ADVISORS LLC | 150,000 | $2,604,000 | 0.10% |
| Candriam S.C.A. | 114,571 | $1,990,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 15,000 | $260,000 | 0.03% |
| Delpha Capital Management, LLC | 1,521 | $26,000 | 0.03% |
| FMR LLC | 9,981,244 | $173,274,000 | 0.02% |